Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 124

    2.

    A comparison of the fungicidal activity of amphotericin B and posaconazole against Zygomycetes in vitro.

    Krishnan-Natesan S, Manavathu EK, Alangaden GJ, Chandrasekar PH.

    Diagn Microbiol Infect Dis. 2009 Apr;63(4):361-4.PMID: 19302924 [PubMed - indexed for MEDLINE]Related articles

    3.

    Aspergillus flavus: an emerging non-fumigatus Aspergillus species of significance.

    Krishnan S, Manavathu EK, Chandrasekar PH.

    Mycoses. 2009 May;52(3):206-22. Epub 2009 Jan 14. Review.PMID: 19207851 [PubMed - indexed for MEDLINE]Related articles

    4.

    Successful treatment of primary cutaneous Aspergillus ustus infection with surgical debridement and a combination of voriconazole and terbinafine.

    Krishnan-Natesan S, Chandrasekar PH, Manavathu EK, Revankar SG.

    Diagn Microbiol Infect Dis. 2008 Dec;62(4):443-6. Epub 2008 Oct 7.PMID: 18842377 [PubMed - indexed for MEDLINE]Related articles

    5.

    Molecular characterisation of cyp51A and cyp51B genes coding for P450 14alpha-lanosterol demethylases A (CYP51Ap) and B (CYP51Bp) from voriconazole-resistant laboratory isolates of Aspergillus flavus.

    Krishnan-Natesan S, Chandrasekar PH, Alangaden GJ, Manavathu EK.

    Int J Antimicrob Agents. 2008 Dec;32(6):519-24. Epub 2008 Sep 4.PMID: 18775650 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effective alternates to trimethoprim-sulfamethoxazole as antimicrobial prophylaxis in stem cell recipients: are there any?

    Ramesh M, Chandrasekar PH.

    Pediatr Transplant. 2008 Dec;12(8):823-6. Epub 2008 Jun 1. No abstract available. PMID: 18518908 [PubMed - indexed for MEDLINE]Related articles

    7.

    Current and future therapeutic options in the management of invasive aspergillosis.

    Krishnan-Natesan S, Chandrasekar PH.

    Drugs. 2008;68(3):265-82. Review.PMID: 18257606 [PubMed - indexed for MEDLINE]Related articles

    8.

    Do Aspergillus species produce biofilm?

    Chandrasekar PH, Manavathu EK.

    Future Microbiol. 2008 Feb;3(1):19-21.PMID: 18230030 [PubMed]Related articles

    9.

    Fluvastatin potentiates the activity of caspofungin against Aspergillus fumigatus in vitro.

    Natesan SK, Chandrasekar PH, Alangaden GJ, Manavathu EK.

    Diagn Microbiol Infect Dis. 2008 Apr;60(4):369-73. Epub 2007 Dec 3.PMID: 18061388 [PubMed - indexed for MEDLINE]Related articles

    10.

    False-positive Aspergillus galactomannan (GM) assay in histoplasmosis.

    Narreddy S, Chandrasekar PH.

    J Infect. 2008 Jan;56(1):80-1. Epub 2007 Nov 5. No abstract available. PMID: 17983658 [PubMed - indexed for MEDLINE]Related articles

    11.

    Rhodococcus equi lung infection in an allogeneic hematopoietic stem cell transplant recipient.

    Cronin SM, Abidi MH, Shearer CJ, Chandrasekar PH, Ibrahim RB.

    Transpl Infect Dis. 2008 Feb;10(1):48-51. Epub 2007 Aug 21.PMID: 17714438 [PubMed - indexed for MEDLINE]Related articles

    12.

    Non-bacterial infections in allogeneic non-myeloablative stem cell transplant recipients.

    Narreddy S, Mellon-Reppen S, Abidi MH, Klein JL, Peres E, Heilbrun LK, Smith D, Alangaden G, Chandrasekar PH.

    Transpl Infect Dis. 2007 Mar;9(1):3-10.PMID: 17313464 [PubMed - indexed for MEDLINE]Related articles

    13.

    Increased dose of echinocandins for invasive fungal infections: bonanza for the patient or the pharmaceutical industry?

    Chandrasekar PH.

    Bone Marrow Transplant. 2007 Feb;39(3):129-31. No abstract available. PMID: 17245422 [PubMed - indexed for MEDLINE]Related articles

    14.

    Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt.

    Anaissie EJ, Segal BH, Graybill JR, Arndt C, Perfect JR, Kleinberg M, Pappas P, Benjamin D, Rubin R, Aberg JA, Adderson EE, Adler-Shohet FC, Akan H, Akova M, Almyroudis NG, Alexander BD, Andes D, Arrieta A, Baddley JW, Barron MA, Belzberg H, Boucher HW, Boyce TG, Casadevall A, Chandrasekar PH, Cleary JD, Cordonnier C, Cornely OA, Cuenca-Estrella M, Daly JS, Daoura N, Denning DW, dePauw B, de Repentigny L, Dignani MC, Dismukes WE, Donnelly JP, Donowitz GR, Dupont B, Drusano G, Ellis M, Espinel-Ingroff A, Fishman JA, Fleming R, Forrest G, Ghannoum M, Goldman M, Grazziutti M, Greene JN, Greenberg RN, Gubbins PO, Hadley S, Herbrecht R, Hiemenz JW, Hope W, Hospenthal DR, Husain S, Ito JI, Jacobson RM, Johnson M, Keating MR, Kett DH, Knapp K, Kontoyiannis DP, Krcmery VC, Larsen R, Laverdiere M, Ljungman P, Lortholary O, Maertens J, Marriott D, Mattiuzzi G, McGinnis MR, Morris M, Nucci M, Odds FC, Pankey GA, Patterson T, Pfaller M, Razonable RR, Reboli AC, Rinaldi MG, Roberts GD, Rodriguez Tudela JL, Rotstein C, Ruhnke M, Schuster M, Shoham S, Sia IG, Siebel N, Silviera F, Singh N, Sobel J, Solomkin JS, Sorrell TC, Steinbach WJ, Temesgen Z, Tortorano A, Vartivarian S, VerWeij P, Viscoli C, Viviani MA, Walker RC, Wheat JL, Wiley J, Williamson P, Wingard JR, Yu VL, Zaoutis T.

    Clin Infect Dis. 2006 Oct 15;43(8):1031-9. Epub 2006 Sep 13. No abstract available. Erratum in: Clin Infect Dis. 2007 Mar 15;44(6):894. PMID: 16983616 [PubMed - indexed for MEDLINE]Related articles

    15.

    Infectious complications after kidney transplantation: current epidemiology and associated risk factors.

    Alangaden GJ, Thyagarajan R, Gruber SA, Morawski K, Garnick J, El-Amm JM, West MS, Sillix DH, Chandrasekar PH, Haririan A.

    Clin Transplant. 2006 Jul-Aug;20(4):401-9.PMID: 16842513 [PubMed - indexed for MEDLINE]Related articles

    16.

    Micafungin: a new echinocandin.

    Chandrasekar PH, Sobel JD.

    Clin Infect Dis. 2006 Apr 15;42(8):1171-8. Epub 2006 Mar 14. Review.PMID: 16575738 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA).

    Ito JI, Chandrasekar PH, Hooshmand-Rad R.

    Bone Marrow Transplant. 2005 Nov;36(10):873-7.PMID: 16113663 [PubMed - indexed for MEDLINE]Related articles

    18.

    Antifungal resistance in Aspergillus.

    Chandrasekar PH.

    Med Mycol. 2005 May;43 Suppl 1:S295-8. Review.PMID: 16110823 [PubMed - indexed for MEDLINE]Related articles

    19.

    A comparative study of fungicidal activities of voriconazole and amphotericin B against hyphae of Aspergillus fumigatus.

    Krishnan S, Manavathu EK, Chandrasekar PH.

    J Antimicrob Chemother. 2005 Jun;55(6):914-20. Epub 2005 Apr 11.PMID: 15824093 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Amphotericin B lipid complex in the management of invasive aspergillosis in immunocompromised patients.

    Chandrasekar PH, Ito JI.

    Clin Infect Dis. 2005 May 1;40 Suppl 6:S392-400.PMID: 15809925 [PubMed - indexed for MEDLINE]Related articles

    21.

    Effect of test medium on in vitro susceptibility testing results for Aspergillus fumigatus.

    Chandrasekar PH, Abraham OC, Manavathu EK, Nune U, Kanuri K.

    Rev Iberoam Micol. 2000 Sep;17(3):107-10.PMID: 15762803 [PubMed]Related articlesFree article

    22.

    In vivo resistance of a laboratory-selected Aspergillus fumigatus isolate to amphotericin B.

    Manavathu EK, Cutright JL, Chandrasekar PH.

    Antimicrob Agents Chemother. 2005 Jan;49(1):428-30.PMID: 15616327 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Real-time polymerase chain reaction for early diagnosis of toxoplasmosis in stem cell transplant recipients: ready for prime time?

    Chandrasekar PH.

    Clin Infect Dis. 2005 Jan 1;40(1):79-81. Epub 2004 Dec 7. No abstract available. PMID: 15614695 [PubMed - indexed for MEDLINE]Related articles

    24.

    In-vitro activity of nikkomycin Z alone and in combination with polyenes, triazoles or echinocandins against Aspergillus fumigatus.

    Ganesan LT, Manavathu EK, Cutright JL, Alangaden GJ, Chandrasekar PH.

    Clin Microbiol Infect. 2004 Nov;10(11):961-6.PMID: 15521997 [PubMed - indexed for MEDLINE]Related articles

    25.

    Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.

    Chandrasekar PH, Cutright JL, Manavathu EK.

    Clin Microbiol Infect. 2004 Oct;10(10):925-8.PMID: 15373889 [PubMed - indexed for MEDLINE]Related articles

    26.

    Fever and eosinophilia associated with voriconazole.

    Vishnubhotla P, Ibrahim RB, Abidi MH, Chandrasekar PH.

    Ann Pharmacother. 2004 May;38(5):900-1. Epub 2004 Mar 23. No abstract available. PMID: 15039477 [PubMed - indexed for MEDLINE]Related articles

    27.

    Novel effect of voriconazole on conidiation of Aspergillus species.

    Varanasi NL, Baskaran I, Alangaden GJ, Chandrasekar PH, Manavathu EK.

    Int J Antimicrob Agents. 2004 Jan;23(1):72-9.PMID: 14732317 [PubMed - indexed for MEDLINE]Related articles

    28.

    A comparative study of the post-antifungal effect (PAFE) of amphotericin B, triazoles and echinocandins on Aspergillus fumigatus and Candida albicans.

    Manavathu EK, Ramesh MS, Baskaran I, Ganesan LT, Chandrasekar PH.

    J Antimicrob Chemother. 2004 Feb;53(2):386-9. Epub 2004 Jan 16.PMID: 14729762 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Voriconazole: A second-generation triazole.

    Chandrasekar PH, Manavathu E.

    Drugs Today (Barc). 2001 Feb;37(2):135-148.PMID: 12783104 [PubMed - as supplied by publisher]Related articles

    30.

    Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.

    Winston DJ, Maziarz RT, Chandrasekar PH, Lazarus HM, Goldman M, Blumer JL, Leitz GJ, Territo MC.

    Ann Intern Med. 2003 May 6;138(9):705-13.PMID: 12729424 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Differential activity of triazoles in two-drug combinations with the echinocandin caspofungin against Aspergillus fumigatus.

    Manavathu EK, Alangaden GJ, Chandrasekar PH.

    J Antimicrob Chemother. 2003 Jun;51(6):1423-5. Epub 2003 Apr 25.PMID: 12716776 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Randomized comparison of oral valacyclovir and intravenous ganciclovir for prevention of cytomegalovirus disease after allogeneic bone marrow transplantation.

    Winston DJ, Yeager AM, Chandrasekar PH, Snydman DR, Petersen FB, Territo MC; Valacyclovir Cytomegalovirus Study Group.

    Clin Infect Dis. 2003 Mar 15;36(6):749-58. Epub 2003 Mar 3.PMID: 12627359 [PubMed - indexed for MEDLINE]Related articles

    33.

    Caspofungin.

    Chandrasekar PH, Manavathu EK.

    Drugs Today (Barc). 2002 Dec;38(12):829-46. Review.PMID: 12582472 [PubMed - indexed for MEDLINE]Related articles

    34.

    Tacrolimus-clarithromycin interaction in a patient receiving bone marrow transplantation.

    Ibrahim RB, Abella EM, Chandrasekar PH.

    Ann Pharmacother. 2002 Dec;36(12):1971-2. No abstract available. PMID: 12452763 [PubMed - indexed for MEDLINE]Related articles

    35.

    Bone and joint infections in injection drug users.

    Kak V, Chandrasekar PH.

    Infect Dis Clin North Am. 2002 Sep;16(3):681-95. Review.PMID: 12371122 [PubMed - indexed for MEDLINE]Related articles

    36.

    Aspergillosis: The most common community-acquired pneumonia with gram-negative Bacilli as copathogens in stem cell transplant recipients with graft-versus-host disease.

    Alangaden GJ, Wahiduzzaman M, Chandrasekar PH; Bone Marrow Transplant Group.

    Clin Infect Dis. 2002 Sep 15;35(6):659-64. Epub 2002 Aug 23.PMID: 12203161 [PubMed - indexed for MEDLINE]Related articles

    37.

    Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

    Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B; Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group.

    N Engl J Med. 2002 Aug 8;347(6):408-15.PMID: 12167683 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    The clinical spectrum of pulmonary aspergillosis.

    Soubani AO, Chandrasekar PH.

    Chest. 2002 Jun;121(6):1988-99. Review.PMID: 12065367 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Aspergillus: rising frequency of clinical isolation and continued susceptibility to antifungal agents, 1994-1999.

    Chandrasekar PH, Cutright JL, Manavathu EK.

    Diagn Microbiol Infect Dis. 2001 Dec;41(4):211-4.PMID: 11777662 [PubMed - indexed for MEDLINE]Related articles

    40.

    Resistance to amphotericin B does not emerge during treatment for invasive aspergillosis.

    Moosa MY, Alangaden GJ, Manavathu E, Chandrasekar PH.

    J Antimicrob Chemother. 2002 Jan;49(1):209-13.PMID: 11751792 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Isolation and in vitro susceptibility to amphotericin B, itraconazole and posaconazole of voriconazole-resistant laboratory isolates of Aspergillus fumigatus.

    Manavathu EK, Abraham OC, Chandrasekar PH.

    Clin Microbiol Infect. 2001 Mar;7(3):130-7.PMID: 11318811 [PubMed - indexed for MEDLINE]Related articles

    42.

    Inhibition of H(+)-ATPase-mediated proton pumping in Cryptococcus neoformans by a novel conjugated styryl ketone.

    Manavathu EK, Dimmock JR, Vashishtha SC, Chandrasekar PH.

    J Antimicrob Chemother. 2001 Apr;47(4):491-4.PMID: 11266429 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Low infectious morbidity after intensive chemotherapy and autologous peripheral blood progenitor cell transplantation in the outpatient setting for women with breast cancer.

    Chandrasekar PH, Abraham OC, Klein J, Alangaden G, Chalasani G, Cassells L, Dansey R, Abella S, Karanes C, Peters W, Baynes R.

    Clin Infect Dis. 2001 Feb 15;32(4):546-51. Epub 2001 Feb 9.PMID: 11181116 [PubMed - indexed for MEDLINE]Related articles

    44.

    Empirical antifungal therapy for persistent fever in patients with neutropenia.

    Chandrasekar PH.

    Clin Infect Dis. 2001 Jan 15;32(2):320-1. No abstract available. PMID: 11170928 [PubMed - indexed for MEDLINE]Related articles

    45.

    Disseminated cytomegalovirus disease in hosts without acquired immunodeficiency syndrome and without an organ transplant.

    Kanno M, Chandrasekar PH, Bentley G, Vander Heide RS, Alangaden GJ.

    Clin Infect Dis. 2001 Jan 15;32(2):313-6. Epub 2000 Dec 28.PMID: 11170926 [PubMed - indexed for MEDLINE]Related articles

    46.

    Cefepime versus ceftazidime as empiric therapy for fever in neutropenic patients with cancer.

    Chandrasekar PH, Arnow PM.

    Ann Pharmacother. 2000 Sep;34(9):989-95.PMID: 10981242 [PubMed - indexed for MEDLINE]Related articles

    48.

    Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. A randomized, double-blind, placebo-controlled trial.

    Prasad AS, Fitzgerald JT, Bao B, Beck FW, Chandrasekar PH.

    Ann Intern Med. 2000 Aug 15;133(4):245-52.PMID: 10929163 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Aspergillus: an increasing problem in tertiary care hospitals?

    Chandrasekar PH, Alangaden G, Manavathu E.

    Clin Infect Dis. 2000 Jun;30(6):984-5. No abstract available. PMID: 10880326 [PubMed - indexed for MEDLINE]Related articles

    50.

    Efficacy of voriconazole against invasive pulmonary aspergillosis in a guinea-pig model.

    Chandrasekar PH, Cutright J, Manavathu E.

    J Antimicrob Chemother. 2000 May;45(5):673-6.PMID: 10797091 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...